TOBRAMYCIN for Cystic fibrosis lung: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 212 adverse event reports in the FDA FAERS database where TOBRAMYCIN was used for Cystic fibrosis lung.
Most Reported Side Effects for TOBRAMYCIN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 1,467 | 12.7% | 158 | 489 |
| Death | 888 | 7.7% | 880 | 50 |
| Cough | 738 | 6.4% | 18 | 260 |
| Dyspnoea | 706 | 6.1% | 22 | 367 |
| Pneumonia | 700 | 6.0% | 43 | 578 |
| Hospitalisation | 688 | 5.9% | 5 | 601 |
| Condition aggravated | 669 | 5.8% | 43 | 439 |
| Cystic fibrosis | 646 | 5.6% | 49 | 520 |
| Infective pulmonary exacerbation of cystic fibrosis | 504 | 4.4% | 16 | 435 |
| Drug ineffective | 453 | 3.9% | 104 | 174 |
| Acute kidney injury | 372 | 3.2% | 32 | 230 |
| Malaise | 361 | 3.1% | 12 | 165 |
| Ill-defined disorder | 344 | 3.0% | 4 | 315 |
| Product use issue | 338 | 2.9% | 52 | 77 |
| Infection | 289 | 2.5% | 16 | 200 |
Other Indications for TOBRAMYCIN
Cystic fibrosis (4,219)
Product used for unknown indication (2,332)
Pseudomonas infection (984)
Bronchiectasis (977)
Off label use (386)
Lung disorder (280)
Pneumonia pseudomonal (170)
Chronic obstructive pulmonary disease (151)
Infective pulmonary exacerbation of cystic fibrosis (144)
Pneumonia (135)
Other Drugs Used for Cystic fibrosis lung
AZTREONAM LYSINE (1,883)
DORNASE ALFA (79)
AZTREONAM (20)
PANCRELIPASE AMYLASE\PANCRELIPASE LIPASE\PANCRELIPASE PROTEASE (20)
ELEXACAFTOR\IVACAFTOR\TEZACAFTOR (12)
PIPERACILLIN\TAZOBACTAM (11)
DUPILUMAB (10)
TOBI PODHALER (10)
COLISTIN (9)
MEROPENEM (9)